Lonial emphasizes that the EXCALIBER-RRMM trial is a test case for a new regulatory framework. The study utilizes dual primary end points to satisfy both accelerated and full approval requirements: ...

For patients facing a multiple myeloma diagnosis, the journey is often defined by a search for the next line of defense. For survivor Julie Cohen, that search led her to the front lines of medical ...

Experts weigh perioperative immunotherapy delays, rapid molecular testing, ctDNA MRD and emerging ADCs shaping early-stage lung cancer care. In this summary of a panel discussion at the 2026 TTLC ...

C4 Therapeutics (NASDAQ:CCCC) used a presentation at TD Cowen’s 46th Annual Healthcare Conference to outline its near- and mid-term clinical plans, emphasizing its lead multiple myeloma program ...

Multiple insider sales by senior executives at Adaptive Biotechnologies (NasdaqGS:ADPT) were disclosed following the company’s strong quarterly results. The CEO and Chief Scientific Officer reported ...

I hope you didn’t make any plans this weekend because Netflix, Hulu and all the other major streamers are streaming can’t-miss new movies. Watch With Us has selected the best of a very impressive ...

The greatest films, released since 2000, that slipped through the cracks when they premiered and now deserve a second look—or first-time discovery. 20th Century Women Mike Mills 25th Hour Spike Lee A ...

Love movies? Live for TV? USA TODAY's Watch Party newsletter has all the best recommendations, delivered right to your inbox. Sign up now and be one of the cool kids. With a little more than a week ...

It’s going to take a lot for the horror movies of 2026 to match last year’s epic films like Weapons and the Oscar-nominated Sinners. In the meantime, horror fans can enjoy most of the best horror ...